EcoDrugPlus

Malt1 Paracaspase

Ensembl ID : ENSAMXG00000016033
Gene Symbol: MALT1
3 Cross references
198 Possible Orthologues:

Map Kinase-Activated Protein Kinase 2

Ensembl ID : ENSAMXG00000044014
Gene Symbol: LOC103033501
3 Cross references
145 Possible Orthologues:

Map Kinase-Activated Protein Kinase 2-Like

Ensembl ID : ENSAMXG00000013599
Gene Symbol: LOC103024512
3 Cross references
170 Possible Orthologues:

Map Kinase-Interacting Serine/threonine-Protein Kinase 2-Like

Ensembl ID : ENSAMXG00000005705
Gene Symbol: LOC103036450
3 Cross references
156 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSAMXG00000042783
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSAMXG00000032889
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSAMXG00000034801
Gene Symbol: MDM2
1 Cross references
285 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSAMXG00000002094
Gene Symbol: MET
1 Cross references
205 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSAMXG00000003867
Gene Symbol: NAALAD2
1 Cross references
340 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSAMXG00000039966
Gene Symbol: LOC103047199
3 Cross references
179 Possible Orthologues:

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSAMXG00000007098
Gene Symbol: NQO1
1 Cross references
179 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSAMXG00000003897
Gene Symbol: NOX4
2 Cross references
150 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).